Control of HIV infection: Escape from the shadow of Blimp-1

European Journal of Immunology

Volumn 43, Issue 2, 2013, Pages 323-326

  Thaventhiran, James E ^a   Fearon, Douglas ^b  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Blimp 1; HIV Infection; Immune exhaustion

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; MICRORNA 9; PROGRAMMED DEATH 1 RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOPTIVE TRANSFER; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNFOLDED PROTEIN RESPONSE; UNTRANSLATED REGION;

ANIMALS; HIV; HIV INFECTIONS; HUMANS; REPRESSOR PROTEINS; T-LYMPHOCYTES;

EID: 84873712646     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243263     Document Type: Note

References (27)

1. Deeks, S. G., Autran, B., Berkhout, B., Benkirane, M., Cairns, S., Chomont, N., Chun, T. W.et al., Towards an HIVcure: a global scientific strategy. Nat. Rev. Immunol. 2012. 12: 607-614.
2. Madec, Y., Boufassa, F., Avettand-Fenoel, V., Hendou, S., Melard, A., Boucherit, S., Surzyn, J. et al., Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort. J. Acquir. Immune. Defic. Syndr. 2009. 50: 19-26.
3. Theze, J., Chakrabarti, L. A., Vingert, B., Porichis, F.andKaufmann, D. E., HIV controllers: a multifactorial phenotype of spontaneous viral suppression. Clin. Immunol. 2011. 141: 15-30.
4. Moskophidis, D., Lechner, F., Pircher, H.and Zinkernagel, R. M., Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993. 362: 758-761.
5. Gallimore, A., Glithero, A., Godkin, A., Tissot, A. C., Pluckthun, A., Elliott, T., Hengartner, H. et al., Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic Tlymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 1998. 187: 1383-1393.
6. Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D. and Ahmed, R., Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 1998. 188: 2205-2213.
7. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W. et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006. 443: 350-354.
8. + T cell exhaustion during chronic viral infection. Immunity 2007. 27: 670-684.
9. Turner, C. A. Jr., Mack, D. H. and Davis, M. M., Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 1994. 77: 297-306.
10. Martins, G. A., Cimmino, L., Shapiro-Shelef, M., Szabolcs, M., Herron, A., Magnusdottir, E. andCalame, K., Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat. Immunol. 2006. 7: 457-465.
11. Kallies, A., Hawkins, E. D., Belz, G. T., Metcalf, D., Hommel, M., Corcoran, L. M., Hodgkin, P. D. et al., Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat. Immunol. 2006. 7: 466-474.
12. Rutishauser, R. L., Martins, G. A., Kalachikov, S., Chandele, A., Parish, I. A., Meffre, E., Jacob, J. et al., Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 2009. 31: 296-308.
13. Kallies, A., Xin, A., Belz, G. T. and Nutt, S. L., Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 2009. 31: 283-295.
14. Martins, G. A., Cimmino, L., Liao, J., Magnusdottir, E. and Calame, K., Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J. Exp. Med. 2008. 205: 1959-1965.
15. Shin, H., Blackburn, S. D., Intlekofer, A. M., Kao, C., Angelosanto, J. M., Reiner, S. L. andWherry, E. J., A role for the transcriptional repressor Blimp-1 in CD8(+) Tcell exhaustion during chronic viral infection. Immunity 2009. 31: 309-320.
16. + Tcells endowed with proliferative capacity. J. Exp. Med. 2003. 198: 1909-1922.
17. Pereyra, F., Addo, M. M., Kaufmann, D. E., Liu, Y., Miura, T., Rathod, A., Baker, B. et al., Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 2008. 197: 563-571.
18. Seddiki, N., Phetsouphanh, C., Swaminathan, S., Xu, Y., Rao, S., Li, J., Sutcliffe, E. L. et al., The miR-9/Blimp-1/IL-2 axis is differentially regulated in progressive HIVinfection. Eur. J. Immunol. 2013. 43: 510-520.
19. Thiele, S., Wittmann, J., Jack, H. M. and Pahl, A., miR-9 enhances IL-2 production in activated human CD4(+) T cells by repressing Blimp-1. Eur. J. Immunol. 2012. 42: 2100-2108.
20. Abrams, D., Levy, Y., Losso, M. H., Babiker, A., Collins, G., Cooper, D. A., Darbyshire, J. et al., Interleukin-2 therapy in patients with HIV infection. N. Engl. J. Med. 2009. 361: 1548-1559.
21. Shankar, E. M., Che, K. F., Messmer, D., Lifson, J. D. and Larsson, M., Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells. Mol. Med. 2010. 17: 229-240.
22. Che, K. F., Shankar, E. M., Muthu, S., Zandi, S., Sigvardsson, M., Hinkula, J., Messmer, D. et al., p38 mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells. Mol. Med. 2012. 18: 1169-1182.
23. Norman, J. P., Perry, S. W., Reynolds, H. M., Kiebala, M., De Mesy Bentley, K. L., Trejo, M., Volsky, D. J. et al., HIV-1 tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One 2008. 3: e3731.
24. Doody, G. M., Stephenson, S.and Tooze, R. M., BLIMP-1 is a target of cellular stress and downstream of the unfolded protein response. Eur. J. Immunol. 2006. 36: 1572-1582.
25. + T cell. Proc. Natl. Acad. Sci. USA. 2012. 109: E2223-E2229.
26. + T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 2007. 8: 1246-1254.
27. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J. et al., Counting Ag-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998. 8: 177-187.